SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.

Trendlines will remain the majority shareholder holding the remaining 79.26% stake in the company, which is valued at $2.5 million.

B. Braun Asia Pacific president Anna Maria Braun, along with Dr Boris Hofmann, director of business development for the B. Braun’s aesculap division, will be joining Trendlines Medical Singapore’s board of directors.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook